跳至主要内容
临床试验/IRCT201109197590N1
IRCT201109197590N1已完成2 期

Comparison the effect of ezetimibe and acarbose on biochemical indices in patient with nonalcoholic fatty liver disease

Vice chancellor for research, Qazvin University of Medical Sciences0 个研究点目标入组 31 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
31

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • 1- the patients diagnosed by means of ultrasound (Bright liver pattern with liver kidney contrast); 2-ALT more than 40 in men and more than 31 in women; 3-Age above18. Exclusion criteria: 1-Type1 or 2 diabetes mellitus; 2-Positive serology for hepatitis; 3-Alcohol consumption more than 20gr per day; 4-History of renal or liver disease; 5-Using drugs like steroids or drugs that influence energy metabolism, intestinal transit, substrate metabolism.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Qazvin University of Medical Sciences

相似试验